Talk with your oncologist about using this approach and ask your oncologist to reach out to Dr. Seyfried at firstname.lastname@example.org.
This week’s New York Times magazine features a story on a theme familiar to all of you readers of this anti-cancer blog : the metabolic approach to starving, or feeding, disease. It singles out insulin and a related hormone, Insulin Growth Factor-1, which we’ve talked about often. And if glucose, glutamine and certain fatty acids drive cancer growth, as the metabolic scientists quoted in the article suggest, then what could be more important than phytonutrients that keep cancer cells from utilizing those fuels? That’s another theme we’ve been addressing. Remember singing the praises of dill?Continue reading →
Ready for some anti-cancer nonsense? This weekend, the Quebec Breast Cancer Foundation is sponsoring– get this– the Montreal Cake Show! Last time I checked the anti-cancer diet books, cake was definitely off the menu.
Could coconut fat help turn the tide in the anti-cancer battle?
Update: Ketogenic diets may not offer the solution that scientists hoped for, but looking at how cancer cells burn fuel for energy is for sure generating insight into how cancer grows and spread. Since this article was published, some scientists have found that cancers can switch to feeding on ketones, which are generated by fat. They’ve also added some fatty acids to the list of nutrients that cancer cells may feed on. Palmitic acid, which is in coconut, may feed cancer, especially in people with certain genetic profiles. The good news is that scientists have also identified phytonutrients that keep cancer cells from using fatty acids as fuels. Among them, luteolin–present in radicchio, thyme, sage, parsley, celery flakes and seeds–is key.
Is the war on cancer now witnessing its own D-Day, a turning point in the anti-cancer fight that will change the world for good?
With the recent settlement of a major lawsuit among scientists over who owns the rights to new revolutionary approaches to managing cancer, all the experts in the field are presumably now free to talk openly—and what they’re talking about is a radical new view of the disease.